Aduro BioTech, Inc.

Aduro BioTech, Inc.

Aduro BioTech, Inc.

Overview
Date Founded

2011

Headquarters

626 Bancroft Way,Suite 3C,Berkeley, CA 94710-2224

Type of Company

Public

Employees (Worldwide)

152

Industries

Pharmaceuticals
Biotechnology

Company Description

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.

Contact Data
Trying to get in touch with decision makers at Aduro BioTech, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman of the Board, President & Chief Executive Officer

Secretary, Senior Vice President & General Counsel

Chief Scientific Officer

Chief Administrative & Legal Officer

Chief Medical Officer

Executive Vice President, Antibody Research & Site Head, Aduro Biotech Europe

Operations Director

Vice President, Project Management & Team Leader

Vice President, Regulatory Affairs

Senior Director

Board of Directors

Chairman of the Board, President & Chief Executive Officer at Aduro BioTech, Inc.

Venture Partner at Third Rock Ventures LLC

Founder & Chief Executive Officer at Triton Systems, Inc.

President & Chief Executive Officer at Cerus Corp.

Founder at PMV Pharmaceuticals, Inc.

Chief Financial & Accounting Officer at Myovant Sciences Ltd.

Principal at Morningside Venture Group LLC

Member, Board of Directors at Aduro BioTech, Inc.

Director at Pinteon Therapeutics, Inc.

Paths to Aduro BioTech, Inc.
Potential Connections via
Relationship Science
You
Aduro BioTech, Inc.
Recent Transactions
Details Hidden

Aduro BioTech, Inc., Aduro Netherlands Coöperatief UA purchase BioNovion BV from Brabantse Ontwikkelings Maatschappij Holding BV, Westertoren Innovation Ventures BV

Details Hidden

Aduro BioTech, Inc. issued Common Stock

Details Hidden

Aduro BioTech, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onAduro BioTech, Inc. issued Common Stock

Legal Advisor

Advised onAduro BioTech, Inc., Aduro Netherlands Coöperatief UA purchase BioNovion BV from Brabantse Ontwikkelings Maatschappij Holding BV, Westertoren Innovation Ventures BV

Underwriter

Advised onAduro BioTech, Inc. issued Common Stock

Legal Advisor

Advised onAduro BioTech, Inc., Aduro Netherlands Coöperatief UA purchase BioNovion BV from Brabantse Ontwikkelings Maatschappij Holding BV, Westertoren Innovation Ventures BV

Legal Advisor

Advised onAduro BioTech, Inc. issued Common Stock

Associate

Advised onAduro BioTech, Inc. issued Common Stock

Advisors & Consultants
Consultant

Chief Medical Officer at Harpoon Therapeutics, Inc.

Consultant

Former Management Consultant at Deloitte LLP

Consultant

Former President & Chief Executive Officer at Inception 2, Inc.

Clients

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Key Stats and Financials As of 2018
Market Capitalization
$91.4M
Total Enterprise Value
$-58.4M
Earnings Per Share
$-1.21
Revenue
$15.1M
Net Profit
$-95.4M
EBITDA
$-80.2M
EBITDAMargin
-531.42%
Total Debt
$0
Total Equity
$135M
Enterprise Value Sales
-3.87x
TEVNet Income
0.61x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
-40.87%
Five Year Compounded Annual Growth Rate Of Revenue
78.7%
Investors
Details Hidden

FMR LLC (Fidelity Management and Research) or Fidelity Investments is an American multinational financial services corporation. It is one of the largest mutual fund and financial services groups in the world. Founded in 1946, the company has since served North American investors. Fidelity Ventures is its venture capital arm. Fidelity International Limited (FIL), was an international affiliate founded in 1969, serving most countries in the rest of the world. In September 2011, FIL was rebranded as 'Fidelity Worldwide Investment'. Fidelity Investments manages a large family of mutual funds provides fund distribution and investment advice services, as well as providing discount brokerage services, retirement services, wealth management, securities execution and clearance, life insurance and a number of other services.

Details Hidden

Johnson & Johnson Development Corp. (JJDC) focuses on in investments in life sciences and technology companies in traditional healthcare sectors including medical devices, diagnostics, pharmaceuticals and consumer products. The firm also invests in emerging healthcare areas including biotechnology and wellness and prevention. JJDC looks for companies with products, services, and technologies that have large addressable markets, clearly-defined competitive advantages and intellectual property protection. They invest in ventures that are backed by an executable clinical and commercialization plan with a clear path to defining and sustaining a leading market position and leveraging competitive advantages to accelerate market adoption and revenue growth.JJDC's investments range from the early stages of seed funding to the advanced stages of series venture management. Investments depend on the stage of funding, phase of product development and alignment of the venture with JJDC's strategic growth objectives and may range from several hundred thousand dollars to millions of dollars. In some advanced stages of funding, the firm will syndicate ventures with other venture capital firms or participate as an investor in a syndicated venture.

Details Hidden

OrbiMed Advisors focuses on investments in the global healthcare industry. They utilizes strategies based on evaluating pharmaceutical, biotechnology, medical device, healthcare services and other companies in the global healthcare sector. The instruments in which OrbiMed invests include US and non-US equities, both long and short, as well as privately placed securities, debt securities, royalty bonds and other royalty instruments, currencies, private investments in public equity securities (PIPEs), ETFs, index options, and derivatives (including swap agreements). The firm invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made across three strategies: public equity, private equity, and royalty opportunities. OrbiMed Advisors manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts. They invest across all types of publicly-traded companies, from biopharmaceuticals to medical devices and healthcare services worldwide. OrbiMed's private equity strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, seeking to help build our portfolio companies. Their geographic focus includes North America, Asia, Europe and Israel. For Royal Opportunities strategy, OrbiMed provides commercial-stage healthcare companies with non-dilutive structured debt capital. Additionally, they can monetize royalty streams, providing valuable financing solutions to owners of intellectual property.

Suppliers
The Rockefeller University Investment Services & Portfolio Management | NEW YORK, NY

The Rockefeller University (the University) is a world renowned center for research (see schedule O) and graduate education in the biomedical sciences, chemistry, bioinformatics, and physics. The University's 77 laboratories conduct both basic and clinical research and study a diverse range of biological and biomedical problems with the mission of improving the understanding of life for the benefit of humanity. Laboratories are loosely clustered in six research areas, including biochemistry, structural biology, and chemistry; medical sciences and human genetics; molecular, cell, and developmental biology; immunology, virology, and microbiology; neuroscience; and physics and mathematical biology. The University does not charge tuition. Its revenues are derived primarily from investment income, government grants and contracts, and private gifts and grants.

The University of Bonn is a public research university located in Bonn, Germany. It was founded in its present form as the Rhein University on 18 October 1818 by Frederick William III, as the linear successor of the Kurkölnische Akademie Bonn (English: Academy of the Prince-elector of Cologne) which was founded in 1777. The University of Bonn offers a large number of undergraduate and graduate programs in a range of subjects and has 544 professors and 32,500 students. Its library holds more than five million volumes. Among its notable alumni and faculty are seven Nobel Laureates, three Fields Medalist, twelve Gottfried Wilhelm Leibniz Prize winners, Prince Albert, Pope Benedict XVI, Frederick III, Karl Marx, Heinrich Heine, Friedrich Nietzsche, Konrad Adenauer, and Joseph Schumpeter. The Times Higher Education World University Rankings 2016 and the Academic Ranking of World Universities 2015 ranked the University of Bonn as one of the 100 best universities in the world.

Rutgers University Human Resources & Personnel Services | NEW BRUNSWICK, NJ

Rutgers, The State University of New Jersey, is a leading national research university and the state’s preeminent, comprehensive public institution of higher education. Rutgers is dedicated to teaching that meets the highest standards of excellence; to conducting research that breaks new ground; and to providing services, solutions, and clinical care that help individuals and the local, national, and global communities where they live. Founded in 1766, Rutgers teaches across the full educational spectrum: preschool to precollege; undergraduate to graduate; postdoctoral fellowships to residencies; and continuing education for professional and personal advancement.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Synlogic, Inc. Biotechnology - Cambridge, MA

Synlogic, Inc. is a clinical-stage biopharmaceutical company, which engages in drug discovery and development of synthetic biotic medicines. It focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Aduro BioTech, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Aduro BioTech, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Aduro BioTech, Inc..